Explore the Global Exosome-Based Neurodegenerative Disease Therapeutics Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Exosome-Based Neurodegenerative Disease Therapeutics Market

Key Insight

FMI opines that the Exosome-Based Neurodegenerative Disease Therapeutics Market was valued at USD 25.9 million in 2025. The industry is expected to reach USD 32.8 million in 2026. Mesenchymal stem cell-derived exosomes are poised to lead by Exosome source/platform with 49.0% share in 2026, and Alzheimer’s disease is estimated to dominate by Indication through 2036.

March 14, 2026

Anurag Sharma

250 Pages

Cite this Report

Exosome-Based Neurodegenerative Disease Therapeutics Market

https://www.futuremarketinsights.com/reports/exosome-based-neurodegenerative-disease-therapeutics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Aruna Bio
Coya Therapeutics
Evox Therapeutics
ILIAS Biologics
NurExone Biologic
ReNeuron Group plc
Vesalic Limited

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Exosome-Based Neurodegenerative Disease Therapeutics Market

Key Players

Similar Industry Reports